Commentary by Rachana Jani MD, PGY-2
As recently reported in ShortCuts, Byetta recently made headlines after the suggestion of a mortality benefit for patients taking the drug in a small subset of the Accord study. So is this the new golden drug …
Clinical Correlations
The NYU Langone Health Online Journal of Medicine
ShortCuts- This Week in the Journals
August 18, 2008
Commentary by Danise Schiliro- Chuang MD
Welcome to this week’s edition of ShortCuts. Hoping as always that this post finds you all doing well. For those of you who have taken or who are …
Class Act: Pathogenesis of Rheumatic Heart Disease
August 14, 2008
Class act is a feature of Clinical Correlations written by NYU 3rd and 4th year medical students. Prior to publication, each commentary is thoroughly reviewed for content by a faculty member.
Commentary by Matt …
FRAX: A Brand New Tool For the Management of Osteoporosis
August 13, 2008
Commentary by Judith Brenner MD, Associate Editor, Clinical Correlations. Reviewed by Valerie Peck MD, NYU Division of Endocrinology.
An 81 year old Caucasian woman with a history of diabetes and hypertension who was …
ShortCuts- This Week in the Journals
August 11, 2008
Commentary by Michael Poles MD, Associate Editor, Clinical Correlations
Well, it is early Saturday morning and I am sitting at my keyboard with coffee in hand. Gotta figure out what interesting tidbits from the world of …
How Do You Approach a Patient with Arthritis and Hepatitis C?
August 7, 2008
Commentary by Peter Izmirly MD, NYU Division of Rheumatology
A 54 year old male with a past medical history significant for hepatitis C genotype 1a s/p ifn/ribavarin 2003-2004 with HCV Qual negative in 2005 presents with 3 weeks …
Clinical Pathology Conference 8/08
August 6, 2008
Case presentation by Kristin Remus DO, NYU Chief Resident
Welcome to the monthly posting of our NYU Department of Medicine’s Clinical Pathology Conference. Use the link below to review the case, followed by a slide presentation of the radiological findings. …
Breaking News: USPSTF Issues New Prostate Cancer Screening Guidelines
August 5, 2008Commentary by Cara Litvin MD, Executive Editor, Clinical Correlations
The US Preventive Services Task Force issued new guidelines for prostate cancer screening on Monday. For the first time, the task force recommends AGAINST routine screening in patients over 75 years of age, citing the “moderate to substantial” harms over small to no benefits from screening. …